A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects

NCT05470101 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ITI-333

Sponsor

Intra-Cellular Therapies, Inc.

Collaborators

[object Object]